PACS Group, Inc.
NYSE:PACSFinancial - Conglomerates
+$0.41 today
- Market cap
- $7.35B
- Beta
- 0.00
- P/E (TTM)
- 23.0
- EPS (TTM)
- $1.55
Volume 0.78M
Average 0.84M
PACS Operating Cash Flow
Cash generated by the company's core business operations during the period.
PACS Group, Inc.NYSE: PACS
Operating Cash Flow · Q2 FY2026 · quarter ended Jun 2026
Operating cash flow growth accelerates
Q2 FY2026 operating cash flow of $135.51M rose 157.7% year over year, ahead of the +20.3% change in trailing-twelve-month operating cash flow. Sequentially, it fell 42.7% from the prior quarter. Over 3 fiscal years it compounded at +63.4% a year.
Context
- Operating cash flow amounted to 7.6% of revenue in FY2025, down 1.3 pp from a year earlier.
- Operating cash flow increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +157.7% holds above the trailing-twelve-month pace of +20.3%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Operating Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 404.22M USD
- Year-over-year change
- +10.0%
- 4-year CAGR
- +62.8%
| Period | Period end | Operating Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 404.22M | +10.0% |
| FY2024 | 2024-12-31 | 367.34M | +476.7% |
| FY2023 | 2023-12-31 | 63.7M | -31.2% |
| FY2022 | 2022-12-31 | 92.62M | +60.8% |
| FY2021 | 2021-12-31 | 57.6M | — |
Operating Cash Flow vs competitors
How PACS compares with its peers on the latest reported figures
- PACS's LTM Jun 2026 operating cash flow of $573.25M is the 4th largest of the 11 companies compared; the peer median is $227M.
- Its year-over-year change of +20.3% is the 7th highest of 11, against a peer median of +27.0%.
- Operating cash flow amounts to 10.3% of revenue for PACS, versus a peer median of 12.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $11.12B | -6.8% | +14.0% | 14.3% | |
| LTM Jun 2026 | $1.21B | +9.7% | +18.5% | 19.5% | |
| LTM Jun 2026 | $608.43M | +31.4% | +27.5% | 11.1% | |
| LTM Jun 2026 | $573.25M | +20.3% | +63.4% | 10.3% | |
| LTM Mar 2026 | $272.68M | +283.7% | +69.9% | 31.0% | |
| LTM Sep 2026 | $232.24M | +1.6% | +305.0% | 7.9% | |
| LTM Sep 2026 | $221.76M | +22.5% | +176.6% | 14.0% | |
| LTM Jun 2026 | $217.87M | +48.9% | +40.4% | 13.7% | |
| LTM Mar 2026 | $126M | -75.0% | +21.9% | 0.6% | |
| LTM Mar 2026 | $66.12M | +277.3% | +74.8% | 6.5% | |
| LTM Mar 2026 | $50.26M | +95.3% | +6.4% | 5.3% | |
| Peer median (excluding PACS) | $227M | +27.0% | +33.9% | 12.4% | |
Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 47.95M | 150.5M | 112.87M | 55.76M | 191.46M |
| Depreciation & Amortization | 7.15M | 22.31M | 25.63M | 40.81M | 55.66M |
| Deferred Income Tax | 7.83M | (1.92M) | (9.92M) | (44.48M) | (17.73M) |
| Stock-Based Compensation | 0 | 0 | 0 | 115.54M | 54.07M |
| Change in Working Capital | (4.36M) | (94.29M) | (94.66M) | 158.22M | 72.71M |
| Accounts Receivables | (40.09M) | (114.62M) | (179.94M) | (116.46M) | 14.43M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 30.78M | 32.81M | 33.37M | 33.4M | 14.86M |
| Other Working Capital | 4.95M | (12.48M) | 51.91M | 241.27M | 43.43M |
| Other Non-Cash Items | (975K) | 16.02M | 29.78M | 41.5M | 48.05M |
| Operating Cash Flow | 57.6M | 92.62M | 63.7M | 367.34M | 404.22M |
| Capital Expenditures | (124.09M) | (22.86M) | (45.78M) | (349.81M) | (105.41M) |
| Acquisitions (Net) | (79.68M) | (55.37M) | (127.02M) | (32.89M) | (143M) |
| Purchases of Investments | (15.71M) | 0 | (2.6M) | (90.87M) | (21.21M) |
| Sales of Investments | 877K | 0 | 1.86M | 25.87M | 5.59M |
| Other Investing Activities | 0 | 2.92M | 750K | 5.02M | 0 |
| Investing Cash Flow | (218.6M) | (75.32M) | (172.79M) | (442.68M) | (264.03M) |
| Debt Repayment | 235.85M | 69.38M | 209.4M | (325.15M) | (60.22M) |
| Common Stock Issued | 0 | 0 | 0 | 509.44M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (53.8M) | (60.28M) | (80.39M) | (33.72M) | 0 |
| Other Financing Activities | 0 | 3.25M | 587K | (33.1M) | (8.77M) |
| Financing Cash Flow | 182.05M | 12.35M | 129.59M | 117.48M | (68.99M) |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 21.05M | 29.64M | 20.5M | 42.14M | 71.21M |
| Free Cash Flow | (66.49M) | 69.75M | 17.92M | 17.53M | 298.82M |
PACS Group, Inc.
NYSE:PACS
Intrinsic Alpha fair value
Locked
Current Price
$46.30
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.